EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Efficacy and safety of Zhishixiaopi decoction in functional dyspepsia: A meta-analysis of randomized controlled trials

Xiankun Zhao iD, Xinyu Cheng, Jing Ye, Jiaqing Ren, Bin Li, Dongmei Tan, Tangshan Li, Kai Zhou, Jing Pu, Xia Luo, Yong Feng iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0301686 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift PLOS ONE, 2024. Verfasst von Xiankun Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional Chinese and Western Medicine, Mianyang Central Hospital, School of Medicine, University of Electronic Science an…. Hauptthemen laut MEDLINE: Dyspepsia, Randomized Controlled Trials as Topic, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Sichuan Nursing Society, The Key Research Base of Humanities and Social Sciences in Colleges and Universities in Sichuan Province, Sichuan Traditional Chinese Medicine Culture Cooperat….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Functional dyspepsia (FD) refers to a group of clinical symptoms caused by gastric and duodenal dysfunction. Which is a chronic functional disorder of the gastrointestinal tract with no cure. Zhishixiaopi decoction (ZSXP) is a type of Chinese herbal prescription that for treating FD. Although some randomized controlled trials (RCTs) report that ZSXP can significantly improve FD clinical symptoms and/or laboratory results, the trial design varies greatly among studies, making it challenging to draw a conclusion of the efficacy of ZSXP in treating FD.

Design

A systematic review and a meta-analysis.

Setting

Mianyang Central Hospital.

Objective

We conducted a systematic review and a meta-analysis to evaluate the efficacy and safety of ZSXP for treating FD.

Methods

We developed inclusion and exclusion criteria based on FD diagnosed criteria, interventions to treat FD, and outcomes of these interventions. Search strategies combined disease terms, symptom terms, anatomy terms and intervention terms. Literature search was conducted on eight online databases in English or Chinese, including Medline (via PubMed), Embase (via Ovid), The Cochrane Library, Web of Science, China Biology Medicine (CBM), China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Database (VIP), and Wanfang Database.

Intervention

The experimental group received oral administration of ZSXP and had a complete treatment process. ZSXP needs to fully contain the key herbal ingredients, regardless of whether the dosage of each herb is consistent with the original prescription. The Control group received monotherapy or combination therapy of other Western medicine and had a complete treatment process. Outcomes The primary outcomes appraised were Total effective rate (TER), serum levels of Motilin(MOT), Gastrin(GAS) and Somatostatin (SS), Gastric emptying rate (GER) using a Barium meal method (GER(B)) and Gastric half emptying time using an Ultrasonic method (GHET(T 1/2 )). The Cochrane Bias Risk Tool was used for quality critical appraisal, Review Manager (RevMan) version 5.3 was used for statistical analysis.

Results

A total of 21 medium-quality RCTs were included in the meta-analysis. All 21 included studies were conducted and completed in Mainland China from 1998 to 2020. The treatment duration was between two weeks to two months. The meta-analysis suggests that, compared with the Western medicine treatment group, ZSXP treatment was more effective to improving the TER in FD [Odds ratio, OR = 3.54, 95%CI:(2.49, 5.05), Z = 6.99, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyspepsiaRandomized Controlled Trials as TopicDrugs, Chinese HerbalHumansTreatment Outcome

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Integrated Traditional Chinese and Western Medicine, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan Province, China.
  • Grand Central Pain Relief, New York, NY, United States of America.
  • Department of Rehabilitation Medicine, West China Second University Hospital of Sichuan University, Chengdu, Sichuan Province, China.
  • Liucheng Street Community Health Service Center, Chengdu, Sichuan Province, China.

ORCID-Profile: Xiankun Zhao, Yong Feng

Förderung

  • The Sichuan Nursing Society
  • The Key Research Base of Humanities and Social Sciences in Colleges and Universities in Sichuan Province, Sichuan Traditional Chinese Medicine Culture Cooperat…

Zitieren

APA

Zhao, X., Cheng, X., Ye, J., Ren, J., Li, B., Tan, D., Li, T., Zhou, K., Pu, J., Luo, X., & Feng, Y. (2024). Efficacy and safety of Zhishixiaopi decoction in functional dyspepsia: A meta-analysis of randomized controlled trials. PLOS ONE. https://doi.org/10.1371/journal.pone.0301686

Vancouver

Zhao X, Cheng X, Ye J, Ren J, Li B, Tan D, et al. Efficacy and safety of Zhishixiaopi decoction in functional dyspepsia: A meta-analysis of randomized controlled trials. PLOS ONE. 2024. doi:10.1371/journal.pone.0301686

BibTeX
@article{Zhao2024,
  author = {Zhao, Xiankun and Cheng, Xinyu and Ye, Jing and Ren, Jiaqing and Li, Bin and Tan, Dongmei and Li, Tangshan and Zhou, Kai and Pu, Jing and Luo, Xia and Feng, Yong},
  title = {Efficacy and safety of Zhishixiaopi decoction in functional dyspepsia: A meta-analysis of randomized controlled trials},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0301686}
}
Kostenlos starten →